DCVC's Life Science Portfolio

ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.

Mapping interactions foundational to therapeutic discovery and human health.

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.

Proxima Bio develops programmable medicines that modulate protein interactions to address disease processes.

Deepcell is a life science company specializing in AI-powered single-cell classification and isolation for basic and translational research.

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.

Superfluid Dx is a biotechnology company developing novel blood-based early detection.

Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.

Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance.